Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 3

Sponsor Class

OTHER 2223INDUSTRY 740NIH 477NETWORK 232OTHER_GOV 42UNKNOWN 3INDIV 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 92Breast 59Thoracic 34Head & Neck 18Lymphoid 16CNS 11Other hematologic neoplasm 7Gynecologic 7Dermatologic 5Tumor-Agnostic 4Genitourinary 4Sarcoma 3Other solid neoplasm 3Other neoplasm 2NET 1Myeloid 1Endocrine 1

Conditions

Sarcoma 2Leiomyosarcoma 1

Interventions

endostar protein 1camrelizumab 1apatinib 1Temozolomide 1Gemcitabine 1Epirubicin 1Endostatins 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × Sarcoma × Clear all
NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

ChineseAMS

Phase NA Unknown
28 enrolled
Sarcoma

Leiomyosarcoma

NCT04447274 2020-06-25

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

ChineseAMS

Phase 2 Unknown
20 enrolled
Sarcoma

Sarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡